Our findings demonstrate a high prevalence of PD stage III/IV in patients with RA and elevated levels of the cytokine APRIL/TNFSF13 in both saliva and serum of RA subjects with severe PD (stage III/IV). Here, TNFSF13 is linked to rheumatoid arthritis.